2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 5, 2000, Pages 529-532

  Purewal, Madhu ^a   Velasco, Marco ^a   Fretland, Adrian J ^b   Hein, David W ^b   Wargovich, Michael J ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ACYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; COLON CARCINOGENESIS; CONTROLLED STUDY; DIET; DOSE RESPONSE; GENOTYPE; HYDROXYLATION; MALE; MICROSOME; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ACETYLATION; ANIMALS; COLORECTAL NEOPLASMS; HUMANS; HYDROXYLATION; IMIDAZOLES; INTESTINAL MUCOSA; MALE; MICROSOMES, LIVER; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; RATS, INBRED WKY;

EID: 0034023575     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sugimura, T. Overview of carcinogenic heterocylic amines. Mut. Res., 376: 211-219, 1997.
2. Layton, D. W., Bogen, K. T., Knize, M. G., Hatch, F. T., Johnson, V. M., and Felton, J. S., Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis (Lond.), 16: 39-52, 1995.
3. Manabe, S., Tohyama, K., Wada, O., and Aramaki, T. Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). in cigarette smoke condensate. Carcinogenesis (Lond.), 12: 1945-1947, 1991.
4. Hasegawa, R., Sano, M., Tamano, S., Imaida, K., Shirai, T., Nagao, M., and Sugimura, T., and Ito N. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) carcinogenicity in rats. Carcinogenesis (Lond.), 14: 2553-2557, 1993.
5. Ito, N., Hasegawa, R., Imaida, K., Tamano, S., Hagiwara, A., Hirose, M., and Shirai, T. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mut. Res., 376: 107-114, 1997.
6. Kaderlik, K. R., Minchin, R. F., Mulder, G. J., Ilett, K. F., Daugaard-Jensen, M., Teitel, C. H., and Kadlubar, F. F. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) in rat extra-hepatic tissues. Carcinogenesis (Lond.), 15: 1703-1709, 1994.
7. Alexander, J., Fossum, B. H., and Holme, J. A. Metabolism of the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) isolated liver cells from guinea pig, hamster, mouse, and rat. Environ. Health Perspect. 102 (Suppl. 6): 109-114, 1994.
8. Hein, D. W., Doll, M. A., Fretland, A. J., Gray, K., Deitz, A. C., Feng, Y., Jiang, W., Rustan, T. D., Satran, S., and Wilkie, T. R., Sr. Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mut. Res., 376: 101-106, 1997.
9. Hein, D. W., Doll, M. A., Fretland, A. J., Leff, M. A., Webb, S. J., Xiao, G. H., Devanaboyina, U.-S., Nangju, N. A., and Feng, Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomark. Prev., 9: 29-42, 2000.
10. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93: 55-71, 1995.
11. Wargovich, M. J., Chen, C. D., Jimenez, A., Steele, V. E., Velasco, M., Stephens, L. C., Price, R., Gray, K., and Kelloff, G. J. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomark. Prev., 5: 355-360, 1996.
12. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V., and Steele, V. E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis (Lond.), 15: 1049-1054, 1994.
13. Ochiai, M., Watanabe, M., Kushida, H., Wadabayashi, K., Sugimura, T., and Nagao, M. DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. Carcinogenesis (Lond.), 17: 95-98, 1996.
14. Ishiguro, Y., Ochiai, M., Sugiumra, T., Nagao, M., and Nakagama, H. Strain differences of rats in the susceptibility of aberrant cypt foci formation by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility. Carcinogenesis (Lond.), 20: 1063-1068, 1999.
15. Remer, H., Grein, H., Schenkman, J. B., and Estabrook, R. W. Methods for the elevation of hepatic microsomal mixed function oxidase levels and cytochrome P-450. Methods Enzymol., 10: 703-708, 1967.
16. Crofts, F. G., Strickland, P. T., Hayes, C. L., and Sutter, T. R. Metabolism of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine by human cytochrome P4501B1. Carcinogenesis (Lond.), 18: 193-198, 1997.
17. Chou, H. C., Lang, N. P., and Kadlubar, F. F. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocylic amines by human sulfotransferase(s). Cancer Res., 55: 525-529, 1995.
18. McLellan, E. A., and Bird, R. P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48: 6187-6192, 1988.
19. Hein, D. W., Rustan, T. D., Bucher, K. D., Furman, E. J., and Martin, W. J. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J. Pharmacol. Exp. Ther., 258: 232-236, 1991.
20. Hein, D. W., Rustan, T. D., Bucher, K. D., Martin, W. J., and Furman, E. J. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab. Dispos., 19: 933-937, 1991.
21. Purewal, M., Fretland, A. J., Schut, H. A. J., Hein, D. W., and Wargovich, M. J. Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats. Cancer Lett., 149: 53-60, 2000.
22. Hein, D. W., Doll, M. A., Gray, K., Rustan, T. D., and Ferguson, R. J. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res., 53: 509-514, 1993.
23. Feng, Y., Fretland, A. J., Jiang, W., Becker, W. K., and Hein, D. W. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2′-dimethyl-4-aminobiphenyl. Toxicol. Appl. Pharmacol., 147: 56-62, 1997.
24. Lang, N. P., Butler, M. A., Massengell, J., Lawson, M., Stotts, R. C., Hauer-Jensen, M., and Kadlubar, F. F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increases the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomark. Prev., 3: 675-682, 1994.
25. Kaderlik, K. R., Mulder, G. J., Shaddock, J. G., Casciano, D. A., Teitel, C. H., and Kadlubar, F. F. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis (Lond.), 15: 1711-1716, 1994.